GlassScriptPhysician profile
Nicole Goitia
NPI 1578124947
$10,595.36
in general payments reported to CMS, 2019-2025
55 companies · $3,109 in 2025
The $3,109 reported for 2025 was more than what 97% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,737 · 2022: $1,000 · 2023: $2,275 · 2024: $2,474 · 2025: $3,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,858.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,625.85 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $922.74 | 2021-2025 | Entyvio, Eohilia, Gattex |
| Janssen Biotech, INC. | $838.67 | 2022-2025 | Stelara, Tremfya, Remicade |
| Gilead Sciences, INC. | $746.07 | 2022-2025 | |
| Genzyme Corporation | $537.64 | 2022-2025 | |
| Pfizer INC. | $447.06 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $444.63 | 2022-2025 | Xifaxan, Trulance |
| Phathom Pharmaceuticals, INC. | $412.74 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $370.08 | 2021-2025 | Omvoh |
| Novo Nordisk INC | $288.77 | 2021-2022 | |
| Celgene Corporation | $201.69 | 2022-2024 | Zeposia |
| Regeneron Healthcare Solutions, INC. | $198.34 | 2022-2025 | Dupixent |
| Amgen INC. | $193.09 | 2021-2025 | Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.85 | 2021-2022 | |
| Madrigal Pharmaceuticals | $129.17 | 2024-2025 | Rezdiffra, Resmetirom |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Goitia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.